IgG4 specific to Toxoplasma gondii excretory/secretory antigens in serum and/or cerebrospinal fluid support the cerebral toxoplasmosis diagnosis in HIV-infected patients

Journal of Immunological Methods

Volumn 395, Issue 1-2, 2013, Pages 21-28

  Meira, Cristina S ^a   Vidal, José E ^b   Costa Silva, Thais A ^a   Motoie, Gabriela ^a   Gava, Ricardo ^a   Hiramoto, Roberto M ^a   Pereira Chioccola, Vera L ^a  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

Author keywords

Antibody response; Cerebral toxoplasmosis and AIDS; ESA proteins; IgG4; Toxoplasma gondii

Indexed keywords

EXCRETORY SECRETORY ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN G4 ANTIBODY; IMMUNOGLOBULIN M; PARASITE ANTIGEN; TACHYZOITE LYSATE ANTIGEN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOCOMPROMISED PATIENT; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REPRODUCIBILITY; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS; VIRUS REACTIVATION;

ANTIBODY RESPONSE; CEREBRAL TOXOPLASMOSIS AND AIDS; ESA PROTEINS; IGG4; TOXOPLASMA GONDII;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; MALE; TOXOPLASMA; TOXOPLASMOSIS, CEREBRAL;

TOXOPLASMA GONDII;

EID: 84881551024     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2013.06.005     Document Type: Article

References (55)

1. Antinori A., Larussa D., Cingolani A., Lorenzini P., Bossolasco S., Finazzi M.G., Bongiovanni M., Guaraldi G., Grisetti S., Vigo B., Gigli B., Mariano A., Dalle Nogare E.R., De Marco M., Moretti F., Corsi P., Abrescia N., Rellecati P., Castagna A., Mussini C., Ammassari A., Cinque P., d'Arminio Monforte A., Italian Registry Investigative NeuroAIDS Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy. Clin. Infect. Dis. 2004, 39:1681.
2. Bèla S.R., Silva D.A.O., Cunha-Júnior J.P., Pirovani C.P., Chaves-Borges F.A., Carvalho F.R., Carrijo de Oliveira T., Mineo J.R. Use of SAG2A recombinant Toxoplasma gondii surface antigen as a diagnostic marker for human acute toxoplasmosis: analysis of titers and avidity of IgG and IgG1 antibodies. Diagn. Microbiol. Infect. Dis. 2008, 62:245.
3. Borges A.S., Figueiredo J.F.C. Evaluation of intrathecal synthesis of specific IgG antibodies against Toxoplasma gondii in the diagnosis assessment of presumptive toxoplasma encephalitis in AIDS patients. Rev. Soc. Bras. Med. Trop. 2004, 6:480.
4. Carruthers V.B. Host cell invasion by the opportunistic pathogen Toxoplasma gondii. Acta Trop. 2002, 81:111.
5. Cesbron-Delauw M.F., Capron A. Excreted-secreted antigens of Toxoplasma gondii: their origin and role in the host-parasite interaction. Res. Immunol. 1993, 144:41.
6. Colombo F.A., Vidal J.E., Penalva de Oliveira A.C., Hernández A.V., Bonasser-Filho F., Nogueira R.S., Focaccia R., Pereira-Chioccola V.L. Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples. J. Clin. Microbiol. 2005, 43:5044.
7. Contini C., Fainardi E., Cultrera R., Canipari R., Peyron F., Delia S., Paolino E., Granieri E. Advanced laboratory techniques for diagnosing Toxoplasma gondii encephalitis in AIDS patients: significance of intrathecal production and comparison with PCR and ECL western blotting. J. Neuroimmunol. 1998, 92:29.
8. Correa D., Cañedo-Solares I., Ortiz-Alegría B., Caballero-Ortega H., Rico-Torres C.P. Congenital and acquired toxoplasmosis: diversity and role of antibodies in different compartments of the host. Parasite Immunol. 2007, 29:651.
9. Costa-Silva T.A., Meira C.S., Ferreira I.M., Hiramoto R.M., Pereira-Chioccola V.L. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii. Exp. Parasitol. 2008, 120:227.
10. Costa-Silva T.A., Meira C.S., Frazzatti-Gallina N., Pereira-Chioccola V.L. Toxoplasma gondii antigens: recovery analysis of tachyzoites cultivated in Vero cell maintained in serum free medium. Exp. Parasitol. 2012, 130:463.
11. Derouin F., Leport C., Pueyo S., Morlat P., Letrillart B., Chene G., Ecobichon J.L., Luft B., Aubertin J., Hafner R., Vilde J.L., Salamon R. Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV-infected patients. AIDS 1996, 10:1521.
12. Dubey J.P. Toxoplasma gondii. Medical Microbiology 1996, The University of Texas, ([Online.] www.ncbi.nlm.nih.gov/books). 5th ed. S. Baron, R.C. Peake, D.A. James, M. Susman, C.A. Kennedy, M.J.D. Singleton, S. Schuenke (Eds.).
13. Dubey J.P. Advances in the life cycle of Toxoplasma gondii. Int. J. Parasitol. 1998, 7:1019.
14. Duquesne V., Auriault C., Darcy F., Decavel J.P., Capron A. Protection of nude rats against Toxoplasma infection by excreted-secreted antigen-specific helper T-cells. Infect. Immun. 1990, 58:2120.
15. Fachado A., Fonte L., Alberti E., Hadad P., Fonseca L., Machin R., Finlay C. Usefulness of the detection of Toxoplasma gondii antigens in AIDS patients. Rev. Inst. Med. Trop. 1994, 36:525.
16. Fatoohi A.F., Cozon G.J., Gonzalo P., Mayencon M., Greenland T., Picot S., Peyron F. Heterogeneity in cellular and humoral immune responses against Toxoplasma gondii antigen in humans. Clin. Exp. Immunol. 2004, 136:535.
17. Gross U., Keksel O., Dardé M.L. Value of detecting immunoglobulin E antibodies for the serologic diagnosis of Toxoplasma gondii infection. Clin. Diagn. Lab. Immunol. 1997, 4:247.
18. Hellerbrand C., Goebel F.D., Disko R. High predictive value of Toxoplasma gondii IgG antibody levels in HIV-infected patients for diagnosis of cerebral toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 1996, 15:869.
19. Hill D.E., Chirukandoth S., Dubey J.P. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim. Health Res. Rev. 2005, 6:41.
20. Hoffmann C. Opportunistic infections 2005, 365. HIV Medicine Flying publisher, ([Online] www.HIVMedicine.com). C. Hoffmann, J.K. Rockstroh, B.S. Kamps (Eds.).
21. Luft B.J., Chua A. Central nervous system toxoplasmosis in HIV: pathogenesis, diagnosis, and therapy. Curr. Infect. Dis. 2000, 2:358.
22. Luft B.J., Remington J.S. Toxoplasmic encephalitis. Clin. Infect. Dis. 1992, 15:211.
23. Mattos C.C., Meira C.S., Ferreira A.I., Frederico F.B., Hiramoto R.M., Jr G.C., Mattos L.C., Pereira-Chioccola V.L. Contribution of laboratory methods in diagnosing clinically suspected ocular toxoplasmosis in Brazilian patients. Diagn. Microbiol. Infect. Dis. 2011, 70:362.
24. Mechain B., Garin Y.J., Robert-Gangneux F., Dupouy-Camet J., Derouin F. Lack of utility of specific immunoglobulin G antibody avidity for serodiagnosis of reactivated toxoplasmosis in immunocompromised patients. Clin. Diagn. Lab. Immunol. 2000, 7:703.
25. Meira C.S., Costa-Silva T.A., Vidal J.E., Ferreira I.M., Hiramoto R.M., Pereira-Chioccola V.L. Use of the serum reactivity against Toxoplasma gondii excreted-secreted antigens in cerebral toxoplasmosis diagnosis in human immunodeficiency virus-infected patients. J. Med. Microbiol. 2008, 57:845.
26. Meira C.S., Vidal J.E., Costa-Silva T.A., Frazatti-Gallina N., Pereira-Chioccola V.L. Immunodiagnosis in cerebrospinal fluid of cerebral toxoplasmosis and HIV-infected patients using Toxoplasma gondii excreted/secreted antigens. Diagn. Microbiol. Infect. Dis. 2011, 71:279.
27. Meulenbroek A.J., Zeijlemaker W.P. Human IgG subclasses: useful diagnostic markers for immunocompetence [online] 1996, Sanquin, Laboratory for Experimental and Clinical Immunology University of Amsterdam, the Netherlands, (http://www.xs4all.nl/~ednieuw/IgGsubclasses/subkl.htm).
28. Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet 2004, 363:1965.
29. Munoz M., Liesenfeld O., Heimesaat M.M. Immunology of Toxoplasma gondii. Immunol. Rev. 2011, 240:269.
30. Nascimento F.S., Suzuki L.A., Rossi C.L. Assessment of the value of detecting specific IgA antibodies for the diagnosis of a recently acquired primary Toxoplasma infection. Prenat. Diagn. 2008, 28:749.
31. Nirula A., Glaser S.M., Kalled S.L., Taylora F.R. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr. Opin. Rheumatol. 2011, 23:119.
32. Nissapatorn V. Toxoplasmosis in HIV/AIDS: a living legacy. Southeast Asian J. Trop. Med. Public Health 2009, 40:1158.
33. Paul M. Use of the ISAGA method in detection of specific IgM, IgA, IgE antibodies in acquired and congenital toxoplasmosis. Wiad. Parazytol. 1997, 43:39.
34. Pereira-Chioccola V.L., Vidal J.E., Su C. Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients. Future Microbiol. 2009, 4:1363.
35. Pinon J.M., Toubas D., Marx C., Mougeot G., Bonnin A., Bonhomme A., Villaume M., Foudrinier F., Lepan H. Detection of specific immunoglobulin E in patients with toxoplasmosis. J. Clin. Microbiol. 1990, 8:1739.
36. Pinon J.M., Foudrinier F., Mougeot G., Marx C., Aubert D., Toupance O., Niel G., Danis M., Camerlynck P., Remy G. Evaluation of risk and diagnostic value of quantitative assays for anti-Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG immunodeficient patients. J. Clin. Microbiol. 1995, 33:878.
37. Pinon J.M., Dumon H., Chemla C., Franck J., Petersen E., Lebech M., Zufferey J., Bessieres M.H., Marty P., Holliman R., Johnson J., Luyasu V., Lecolier B., Guy E., Joynson D.H., Decoster A., Enders G., Pelloux H., Candolfi E. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J. Clin. Microbiol. 2001, 39:2267.
38. Portegies P., Solod L., Cinque P., Chaudhuri A., Begovac J., Everall I., Weber T., Bojar M., Martinez-Martin P., Kennedy G.E. Guidelines for the diagnosis and management of neurological complications of HIV infection. Eur. J. Neurol. 2004, 11:297.
39. Potasman I., Resnick L., Luft B.J., Remington J.S. Intrathecal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the acquired immunodeficiency syndrome AIDS. Ann. Intern. Med. 1988, 108:49.
40. Prigione I., Facchetti P., Lecordier L., Deslee D., Chiesa S., Cesbron-Delauw M.F., Pistoia V. T cell clones raised from chronically infected healthy humans by stimulation with Toxoplasma gondii excretory-secretory antigens cross-react with live tachyzoites: characterization of the fine antigenic specificity of the clones and implications for vaccine development. J. Immunol. 2000, 7:3741.
41. Raffi F., Aboulker J.P., Michelet C., Reliquet V., Pelloux H., Huart A., Poizot-Martin I., Morlat P., Dupas B., Mussini J.M., Leport C. A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients. AIDS 1997, 11:177.
42. Salfeld J.G. Isotype selection in antibody engineering. Nat. Biotechnol. 2007, 25:1369.
43. Santana S.S., Silva D.A.O., Vaz L.D., Pirovani C.P., Barros G.B., Lemos E.M., Dietze R., Mineo J.R., Cunha-Junior J.P. Analysis of IgG subclasses (IgG1 and IgG3) to recombinant SAG2A protein from Toxoplasma gondii in sequential serum samples from patients with toxoplasmosis. Immunol. Lett. 2012, 143:193.
44. Sarciron M.E., Gherardi A. Cytokines involved in toxoplasmic encephalitis. Scand. J. Immunol. 2000, 52:534.
45. Singh J., Graniello C., Yanyan N.I., Payne L., Sa Q., Hester J., Shelton B.J., Suzuki Y. Toxoplasma IgG and IgA, but not IgM, antibody titers increase in sera of immunocompetent mice in association with proliferation of tachyzoites in the brain during the chronic stage of infection. Microbes Infect. 2010, 12:1252.
46. Skiest D.J. Focal neurological disease in patients with acquired immunodeficiency syndrome. Clin. Infect. Dis. 2002, 34:103.
47. Souza e Silva C.H., Andrade G.Q., Januário J.N., Carneiro A.C.A.V., Carneiro M., Vasconcelos-Santos D.V., Vitor R.W.A. Early diagnosis of congenital toxoplasmosis in newborn infants using IgG subclasses against two Toxoplasma gondii recombinant proteins. Mem. Inst. Oswaldo Cruz 2012, 107:342.
48. Stone J.H., Zen Y., Deshpande V. IgG4-related disease. N. Engl. J. Med. 2012, 366:539.
49. Tilley M., Fichera M.E., Jerome M.E., Roos D.S., White M.W. Toxoplasma gondii sporozoites from a transient parasitophorus vacuole that is impermeable and contains only a subset of dense granule proteins. Infect. Immun. 1997, 65:4598.
50. Vidal J.E., Colombo F.A., Penalva de Oliveira A.C., Focaccia R., Pereira-Chioccola V.L. PCR assay using cerebrospinal fluid for diagnosis of cerebral toxoplasmosis in Brazilian AIDS patients. J. Clin. Microbiol. 2004, 42:4765.
51. Vidal J.E., Hernandez A.V., Penalva de Oliveira A.C., Dauar R., Barboza S.P., Focaccia R. Cerebral toxoplasmosis in HIV-Positive patients in Brazil: clinical features and predictors of treatment response in the HAART era. AIDS Patient Care STDS 2005, 19:840.
52. Vidal J.E., Diaz A.V.H., Penalva de Oliveira A.C., Dauar R.F., Colombo F.A., Pereira-Chioccola V.L. Importance of high IgG anti-Toxoplasma gondii titers and PCR detection of T. gondii DNA in peripheral blood samples for the diagnosis of AIDS-related cerebral toxoplasmosis: a case-control study. Braz. J. Infect. Dis. 2011, 15:356.
53. Wong S.Y., Remington J.S. Biology of Toxoplasma gondii. AIDS 1993, 7:299.
54. Zeman A., McLean B., Keir G., Luxton R., Sharief M., Thompson E. The significance of serum oligoclonal bands in neurological diseases. J. Neurol. Neurosurg. Psychiatry 1993, 56:32.
55. Zenner L., Estaquier J., Darcy F., Maes P., Capron A., Caesbron-Delauw M.F. Protective immunity in the rat model of congenital toxoplasmosis and the potential vaccinal role of excreted-secreted antigens (ESA). Parasite Immunol. 1999, 21:261.